Pharmacologically Diverse Antidepressants Rapidly Activate Brain-Derived Neurotrophic Factor Receptor TrkB and Induce Phospholipase-Cγ Signaling Pathways in Mouse Brain
The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Abstract
Previous studies suggest that brain-derived neurotrophic factor and its receptor TrkB are critically involved in the therapeutic actions of antidepressant drugs. We have previously shown that the antidepressants imipramine and fluoxetine produce a rapid autophosphorylation of TrkB in the rodent brain. In the present study, we have further examined the biochemical and functional characteristics of antidepressant-induced TrkB activation in vivo. We show that all the antidepressants examined, including inhibitors of monoamine transporters and metabolism, activate TrkB rapidly in the rodent anterior cingulate cortex and hippocampus. Furthermore, the results indicate that acute and long-term antidepressant treatments induce TrkB-mediated activation of phospholipase-Cgamma1 (PLCgamma1) and increase the phosphorylation of cAMP-related element binding protein, a major transcription factor mediating neuronal plasticity. In contrast, we have not observed any modulation of the phosphorylation of TrkB Shc binding site, phosphorylation of mitogen-activated protein kinase or AKT by antidepressants. We also show that in the forced swim test, the behavioral effects of specific serotonergic antidepressant citalopram, but not those of the specific noradrenergic antidepressant reboxetine, are crucially dependent on TrkB signaling. Finally, brain monoamines seem to be critical mediators of antidepressant-induced TrkB activation, as antidepressants reboxetine and citalopram do not produce TrkB ac…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Research on the biological connections demonstrated that antidepressants activate the BDNF via tropomyosin receptor kinase B (TrkB) and a common transcription factor cAMP response element-binding protein (CREB; Koponen et al., 2005;Rantamaki et al., 2007).”
From Serotonin and neuroplasticity – Links between molecular, functional and structural pathophysiology in depression (2017) · cites this paper as Rantamaki et al., 2007
In the citing paper
“Antidepressant drugs require functional TrkB receptors to mediate antidepressant-like response in preclinical models (Rantamäki et al., 2007; Saarelainen et al., 2003).”
From BDNF - a key transducer of antidepressant effects (2016) · cites this paper as Rantamäki et al., 2007
In the citing paper
“Rather intriguingly, chronic antidepressant treatment increases the phosphorylation of the TrkB receptor, thus increasing its activity, in the hippocampus and anterior cingulate cortex suggesting that BDNF-TrkB signaling in these brain regions may be critical in mediating antidepressant effects (Rantamäki et al., 2007).”
From BDNF - a key transducer of antidepressant effects (2016) · cites this paper as Rantamäki et al., 2007
In the citing paper
“autophosphorylation of TrkB by antidepressants has also been reported by the group of Castren (Rantamaki et al. 2007; Saarelainen et al. 2003)”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Rantamaki et al. 2007
In the citing paper
“Other studies have found that antidepressants from a variety of chemical families (e.g., SSRIs, SNRIs, tricyclics, etc.) all increase activation of TrkB and its downstream effector CREB (140).”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [140]
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Depression: a new animal model sensitive to antidepressant treatments
PORSOLT, R. D., LE PICHON, M., & JALFRE, M. (1977) · Nature · doi:10.1038/266730a0 · Cited by 4,451 · cited 4×
“Selected antidepressant doses have been routinely used in rodent models of behavioral despair (Porsolt et al, 1977; Wong et al, 2000; Drago et al, 2001; Weinstock et al, 2002; O’Leary et al, 2007).”
InfluentialNeurotrophins: Roles in Neuronal Development and Function
Huang, E. J., & Reichardt, L. F. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.677 · Cited by 4,394
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321 · cited 2×
“This FLX administration protocol has been previously shown to produce long-term alterations in neuroplasticity and animal behavior (Santarelli et al, 2003).”
InfluentialEgan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00035-7 · Cited by 3,888 · cited 1×
“Furthermore, val/met polymorphism in BDNF gene, which influences the activity-dependent BDNF release (Egan et al, 2003) has recently been associated with mood disorders in humans (Sklar et al, 2002; Lang et al, 2005).”
Nestler, E. J., Barrot, M., DiLeone, R. J., Eisch, A. J., Gold, S. J., & Monteggia, L. M. (2002) · Neuron · doi:10.1016/s0896-6273(02)00653-0 · Cited by 3,217
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129
Nibuya, M., Morinobu, S., & Duman, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07539.1995 · Cited by 2,109 · cited 4×
“In addition, antidepressants block and accelerate the reversion of stress-induced downregulation in BDNF mRNA and protein, respectively (Nibuya et al, 1995; Xu et al, 2004).”
InfluentialBrain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression
Shirayama, Y., Chen, A. C.-H., Nakagawa, S., Russell, D. S., & Duman, R. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03251.2002 · Cited by 1,654
Smith, M., Makino, S., Kvetnansky, R., & Post, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-03-01768.1995 · Cited by 1,440
Cited by
Brain-Derived Neurotrophic Factor and Neuropsychiatric Disorders
Autry, A. E., & Monteggia, L. M. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.005108 · Cited by 1,390
“In a subsequent study, antidepressant drugs were found to rapidly activate the TrkB receptor and PLC signaling, which suggests that this intracellular pathway is a common mechanism for antidepressant drug action (Rantamäki et al., 2007).”
Mechanisms of ketamine action as an antidepressant
Zanos, P., & Gould, T. D. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.255 · Cited by 1,127
BDNF - a key transducer of antidepressant effects
Björkholm, C., & Monteggia, L. M. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.10.034 · Cited by 958
“…of BDNF signaling in the response to antidepressants has come from studies examining the high affinity BDNF receptor, TrkB. Antidepressant drugs require functional TrkB receptors to mediate antidepressant-like response in preclinical models (Rantamäki et al., 2007; Saarelainen et al., 2003).”
BackgroundCastrén, E., & Rantamäki, T. (2010) · Developmental Neurobiology · doi:10.1002/dneu.20758 · Cited by 864
Self-citationAntidepressant drugs act by directly binding to TRKB neurotrophin receptors
Casarotto, P. C., Girych, M., Fred, S. M., Kovaleva, V., Moliner, R., Enkavi, G., Biojone, C., Cannarozzo, C., Sahu, M. P., Kaurinkoski, K., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.034 · Cited by 663
Self-citationBDNF signaling in context: From synaptic regulation to psychiatric disorders
Wang, C. S., Kavalali, E. T., & Monteggia, L. M. (2022) · Cell · doi:10.1016/j.cell.2021.12.003 · Cited by 607
Wang, J.-W., David, D. J., Monckton, J. E., Battaglia, F., & Hen, R. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3632-07.2008 · Cited by 550
Brain-Derived Neurotrophic Factor Signaling in Depression and Antidepressant Action
Castrén, E., & Monteggia, L. M. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.05.008 · Cited by 540
Moylan, S., Maes, M., Wray, N. R., & Berk, M. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.33 · Cited by 529
Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors
Vargas, M. V., Dunlap, L. E., Dong, C., Carter, S. J., Tombari, R. J., Jami, S. A., Cameron, L. P., Patel, S. D., Hennessey, J. J., Saeger, H. N., et al. (2023) · Science · doi:10.1126/science.adf0435 · Cited by 489
The role of 5-HT receptors in depression
Yohn, C. N., Gergues, M. M., & Samuels, B. A. (2017) · Molecular Brain · doi:10.1186/s13041-017-0306-y · Cited by 485
Psychedelics promote plasticity by directly binding to BDNF receptor TrkB
Moliner, R., Girych, M., Brunello, C. A., Kovaleva, V., Biojone, C., Enkavi, G., Antenucci, L., Kot, E. F., Goncharuk, S. A., Kaurinkoski, K., et al. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01316-5 · Cited by 478
Kraus, C., Castrén, E., Kasper, S., & Lanzenberger, R. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.03.007 · Cited by 471
Phillips, C. (2017) · Neural Plasticity · doi:10.1155/2017/7260130 · Cited by 450
Kubera, M., Obuchowicz, E., Goehler, L., Brzeszcz, J., & Maes, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.08.026 · Cited by 443
Fear erasure in mice requires synergy between antidepressant drugs and extinction training
Karpova, N. N., Pickenhagen, A., Lindholm, J., Tiraboschi, E., Kulesskaya, N., Ágústsdóttir, A., Antila, H., Popova, D., Akamine, Y., Sullivan, R., et al. (2011) · Science · doi:10.1126/science.1214592 · Cited by 382
Antidepressant‐like effects of cannabidiol in mice: possible involvement of 5‐HT1Areceptors
Zanelati, T., Biojone, C., Moreira, F., Guimarães, F., & Joca, S. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00521.x · Cited by 366
Brain-derived neurotrophic factor: role in depression and suicide
Dwivedi, Y. (2009) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s5700 · Cited by 355
Brain-derived neurotrophic factor in mood disorders and antidepressant treatments
Castrén, E., & Kojima, M. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.07.010 · Cited by 337
Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression
Levy, M. J. F., Boulle, F., Steinbusch, H. W., van den Hove, D. L. A., Kenis, G., & Lanfumey, L. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4950-4 · Cited by 308
“It includes different mechanisms as described in an excellent review by Castren and Hen (2013).”
InfluentialZhang, J.-C., Wu, J., Fujita, Y., Yao, W., Ren, Q., Yang, C., Li, S.-X., Shirayama, Y., & Hashimoto, K. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu077 · Cited by 289
“It is also reported that a single dose of SSRIs, such as fluoxetine and citalopram, could rapidly activate TrkB phosphorylation in the brain (Rantamäki et al., 2007).”
BackgroundNeuronal plasticity and neurotrophic factors in drug responses
Castrén, E., & Antila, H. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.61 · Cited by 284
Onishchenko, N., Karpova, N., Sabri, F., Castrén, E., & Ceccatelli, S. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05484.x · Cited by 263
Masi, G., & Brovedani, P. (2011) · CNS Drugs · doi:10.2165/11595900-000000000-00000 · Cited by 260
Matrisciano, F., Bonaccorso, S., Ricciardi, A., Scaccianoce, S., Panaccione, I., Wang, L., Ruberto, A., Tatarelli, R., Nicoletti, F., Girardi, P., et al. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.03.014 · Cited by 253
Ketamine: A tale of two enantiomers
Jelen, L. A., Young, A. H., & Stone, J. M. (2021) · Journal of Psychopharmacology · doi:10.1177/0269881120959644 · Cited by 246
BDNF effects on dendritic spine morphology and hippocampal function
von Bohlen und Halbach, O., & von Bohlen und Halbach, V. (2018) · Cell and Tissue Research · doi:10.1007/s00441-017-2782-x · Cited by 218
“Indeed, diverse antidepressants have been shown to activate receptor trkB and induce PLCgamma signaling pathways, at least in the mouse brain (Rantamaki et al. 2007).”
N -acetylserotonin activates TrkB receptor in a circadian rhythm
Jang, S.-W., Liu, X., Pradoldej, S., Tosini, G., Chang, Q., Iuvone, P. M., & Ye, K. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912531107 · Cited by 214
Liu, X., Chan, C.-B., Jang, S.-W., Pradoldej, S., Huang, J., He, K., Phun, L. H., France, S., Xiao, G., Jia, Y., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm101206p · Cited by 208
Vagal nerve stimulation for treatment-resistant depression
Carreno, F. R., & Frazer, A. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0537-8 · Cited by 208
Correll, C. U., Hauser, M., Auther, A. M., & Cornblatt, B. A. (2010) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2010.02235.x · Cited by 194
BDNF isoforms: a round trip ticket between neurogenesis and serotonin?
Foltran, R. B., & Diaz, S. L. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13658 · Cited by 187
Haase, J., & Brown, E. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.10.002 · Cited by 175
Convergent Mechanisms Underlying Rapid Antidepressant Action
Zanos, P., Thompson, S. M., Duman, R. S., Zarate, C. A., & Gould, T. D. (2018) · CNS Drugs · doi:10.1007/s40263-018-0492-x · Cited by 171
Castagné, V., Porsolt, R. D., & Moser, P. C. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.06.018 · Cited by 168
Psychedelics and Other Psychoplastogens for Treating Mental Illness.
Vargas, M. V., Meyer, R., Avanes, A. A., Rus, M., & Olson, D. E. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.727117 · Cited by 166
Karpova, N. N., Lindholm, J., Pruunsild, P., Timmusk, T., & Ċastrén, E. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.09.002 · Cited by 165
Pattwell, S. S., Bath, K. G., Perez-Castro, R., Lee, F. S., Chao, M. V., & Ninan, I. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.5205-11.2012 · Cited by 156
Self-citationDeltheil, T., Guiard, B. P., Cerdan, J., David, D. J., Tanaka, K. F., Repérant, C., Guilloux, J.-P., Coudoré, F., Hen, R., & Gardier, A. M. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.08.001 · Cited by 153
TrkB/BDNF signaling pathway and its small molecular agonists in CNS injury
Wang, Y., Liang, J., Xu, B., Yang, J., Wu, Z., & Cheng, L. (2024) · Life Sciences · doi:10.1016/j.lfs.2023.122282 · Cited by 152
Wager-Smith, K., & Markou, A. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.09.010 · Cited by 151
Neurotrophins and Psychiatric Disorders
Castrén, E. (2014) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-45106-5_17 · Cited by 150
McKernan, D. P., Dinan, T. G., & Cryan, J. F. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.04.006 · Cited by 147
Kohtala, S. (2021) · Pharmacological Reports · doi:10.1007/s43440-021-00232-4 · Cited by 142
Sigma receptors: Potential targets for a new class of antidepressant drug
Fishback, J. A., Robson, M. J., Xu, Y.-T., & Matsumoto, R. R. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.04.003 · Cited by 125
The role of neurotrophins in major depressive disorder
Jiang, C., & Salton, S. (2013) · Translational Neuroscience · doi:10.2478/s13380-013-0103-8 · Cited by 113
Chen, M. J., & Russo‐Neustadt, A. A. (2009) · Hippocampus · doi:10.1002/hipo.20579 · Cited by 129
“On the other hand, more recent studies have examined cellular effects of very short-term antidepressant treatment, and a few agents increase BDNF expression within 4–6 h (Sacchetti et al., 1999; Dias et al., 2003; Saarelainen et al., 2003; Vaynman et al., 2003; Rantamaki et al., 2007).”
Tejeda, G., & Díaz-Guerra, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020268 · Cited by 126
Markham, A., Bains, R., Franklin, P., & Spedding, M. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12531 · Cited by 111
Rantamäki, T., Vesa, L., Antila, H., Di Lieto, A., Tammela, P., Schmitt, A., Lesch, K.-P., Rios, M., & Castrén, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020567 · Cited by 124
Self-citationShared biological mechanisms of depression and obesity: focus on adipokines and lipokines
Fu, X., Wang, Y., Zhao, F., Cui, R., Xie, W., Liu, Q., & Yang, W. (2023) · Aging · doi:10.18632/aging.204847 · Cited by 124
Transient stimulation with psychoplastogens is sufficient to initiate neuronal growth
Ly, C., Greb, A. C., Vargas, M. V., Duim, W. C., Grodzki, A. C. G., Lein, P. J., & Olson, D. E. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00065 · Cited by 123
Castrén, E., & Rantamäki, T. (2010) · CNS Drugs · doi:10.2165/11530010-000000000-00000 · Cited by 123
Self-citationGéral, C., Angelova, A., & Lesieur, S. (2013) · Pharmaceutics · doi:10.3390/pharmaceutics5010127 · Cited by 123
Herrera-Guzmán, I., Herrera-Abarca, J. E., Gudayol-Ferré, E., Herrera-Guzmán, D., Gómez-Carbajal, L., Peña-Olvira, M., Villuendas-González, E., & Joan, G.-O. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2010.03.006 · Cited by 120
Yi, L.-T., Li, J., Liu, B.-B., Luo, L., Liu, Q., & Geng, D. (2014) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.130169 · Cited by 119
Mice with altered BDNF signaling as models for mood disorders and antidepressant effects
Lindholm, J. S. O., & Castrén, E. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00143 · Cited by 114
Role of the Astroglial Glutamate Exchanger xCT in Ventral Hippocampus in Resilience to Stress
Nasca, C., Bigio, B., Zelli, D., de Angelis, P., Lau, T., Okamoto, M., Soya, H., Ni, J., Brichta, L., Greengard, P., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.09.020 · Cited by 113
Haenisch, B., Bilkei‐Gorzo, A., Caron, M. G., & Bönisch, H. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06345.x · Cited by 113
“Recent studies indicate that ADs rapidly activate TrkB signaling and induce a long-lasting increase in BDNF production (Castren et al. 2007; Rantamäki et al. 2007).”
BackgroundLindholm, J., Autio, H., Vesa, L., Antila, H., Lindemann, L., Hoener, M. C., Skolnick, P., Rantamäki, T., & Ċastrén, E. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.015 · Cited by 112
Self-citationPrimary phospholipase C and brain disorders
Yang, Y. R., Kang, D.-S., Lee, C., Seok, H., Follo, M. Y., Cocco, L., & Suh, P.-G. (2016) · Advances in Biological Regulation · doi:10.1016/j.jbior.2015.11.003 · Cited by 101
Serotonergic Modulation of Intrinsic Functional Connectivity
Schaefer, A., Burmann, I., Regenthal, R., Arélin, K., Barth, C., Pampel, A., Villringer, A., Margulies, D. S., & Sacher, J. (2014) · Current Biology · doi:10.1016/j.cub.2014.08.024 · Cited by 106
Pharmacometabolomic mapping of early biochemical changes induced by sertraline and placebo
Kaddurah-Daouk, R., Bogdanov, M. B., Wikoff, W. R., Zhu, H., Boyle, S. H., Churchill, E., Wang, Z., Rush, A. J., Krishnan, R. R., Pickering, E., et al. (2013) · Translational Psychiatry · doi:10.1038/tp.2012.142 · Cited by 101
Impaired TrkB receptor signaling contributes to memory impairment in APP/PS1 mice
Kemppainen, S., Rantamäki, T., Jerónimo-Santos, A., Lavasseur, G., Autio, H., Karpova, N. N., Kärkkäinen, E., Stavén, S., Miranda, H. V., Outeiro, T. F., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.11.006 · Cited by 101
Self-citationFurmaga, H., Carreno, F. R., & Frazer, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034844 · Cited by 99
Swift, J. L., Godin, A. G., Doré, K., Freland, L., Bouchard, N., Nimmo, C., Sergeev, M., De Koninck, Y., Wiseman, P. W., & Beaulieu, J.-M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018280108 · Cited by 90
Functional interactions between steroid hormones and neurotrophin BDNF
Numakawa, T., Yokomaku, D., Richards, M., Hori, H., Adachi, N., & Kunugi, H. (2010) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v1.i5.133 · Cited by 98
Multiplex quantitative assays indicate a need for reevaluating reported small-molecule TrkB agonists
Boltaev, U., Meyer, Y., Tolibzoda, F., Jacques, T., Gassaway, M., Xu, Q., Wagner, F., Zhang, Y.-L., Palmer, M., Holson, E., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aal1670 · Cited by 94
Duclot, F., & Kabbaj, M. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0199-13.2013 · Cited by 85
Burnouf, S., Martire, A., Derisbourg, M., Laurent, C., Belarbi, K., Leboucher, A., Fernandez‐Gomez, F. J., Troquier, L., Eddarkaoui, S., Grosjean, M., et al. (2013) · Aging Cell · doi:10.1111/acel.12018 · Cited by 79
Future antidepressant targets: neurotrophic factors and related signaling cascades
Schmidt, H. D., Banasr, M., & Duman, R. S. (2008) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2008.10.003 · Cited by 93
Mood disorders in Huntington's disease: from behavior to cellular and molecular mechanisms
Pla, P., Orvoen, S., Saudou, F., David, D. J., & Humbert, S. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00135 · Cited by 91
Neuropeptides in depression: Role of VGF
Thakker-Varia, S., & Alder, J. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.10.006 · Cited by 86
Phospholipase C-γ1 involved in brain disorders
Jang, H., Yang, Y. R., Kim, J. K., Choi, J. H., Seo, Y., Lee, Y. H., Lee, J. E., Ryu, S. H., & Suh, P. (2012) · Advances in Biological Regulation · doi:10.1016/j.jbior.2012.09.008 · Cited by 86
Han, X., Tong, J., Zhang, J., Farahvar, A., Wang, E., Yang, J., Samadani, U., Smith, D. H., & Huang, J. H. (2011) · Journal of Neurotrauma · doi:10.1089/neu.2010.1563 · Cited by 85
Emili, M., Guidi, S., Uguagliati, B., Giacomini, A., Bartesaghi, R., & Stagni, F. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1810625 · Cited by 85
A role for BDNF/TrkB signaling in behavioral and physiological consequences of social defeat stress
Razzoli, M., Domenici, E., Carboni, L., Rantamaki, T., Lindholm, J., Castrén, E., & Arban, R. (2011) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2011.00681.x · Cited by 77
Self-citationIsoflurane produces antidepressant effects and induces TrkB signaling in rodents
Antila, H., Ryazantseva, M., Popova, D., Sipilä, P., Guirado, R., Kohtala, S., Yalcin, I., Lindholm, J., Vesa, L., Sato, V., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-08166-9 · Cited by 84
Self-citationBarriga, G. G.-D., Giralt, A., Anglada‐Huguet, M., Gaja‐Capdevila, N., Orlandi, J. G., Soriano, J., Canals, J. M., & Alberch, J. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx198 · Cited by 85
Impact of Traumatic Brain Injury on Neurogenesis
Ngwenya, L. B., & Danzer, S. C. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.01014 · Cited by 68
The antidepressant mechanism of action of vagus nerve stimulation: Evidence from preclinical studies
Grimonprez, A., Raedt, R., Baeken, C., Boon, P., & Vonck, K. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.06.019 · Cited by 81
iPlasticity: Induced juvenile‐like plasticity in the adult brain as a mechanism of antidepressants
Umemori, J., Winkel, F., Didio, G., Llach Pou, M., & Castrén, E. (2018) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12683 · Cited by 80
Marton, S., González, B., Rodríguez-Bottero, S., Miquel, E., Palma, L. M., Pazos, M., Prieto, J. P., Rodríguez, P., Sameš, D., Seoane, G. A., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00193 · Cited by 80
Thakker-Varia, S., Behnke, J., Doobin, D., Dalal, V., Thakkar, K., Khadim, F., Wilson, E., Palmieri, A., Antila, H., Rantamaki, T., et al. (2014) · Stem Cell Research · doi:10.1016/j.scr.2014.03.005 · Cited by 65
Self-citationN -Acetylserotonin: Neuroprotection, Neurogenesis, and the Sleepy Brain
Tosini, G., Ye, K., & Iuvone, P. M. (2012) · The Neuroscientist · doi:10.1177/1073858412446634 · Cited by 76
Eriksson, T. M., Delagrange, P., Spedding, M., Popoli, M., Mathé, A. A., Ögren, S. O., & Svenningsson, P. (2012) · Molecular Psychiatry · doi:10.1038/mp.2010.131 · Cited by 73
Differential effects of acute and repeated citalopram in mouse models of anxiety and depression
Mombereau, C., Gur, T. L., Onksen, J., & Blendy, J. A. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990630 · Cited by 73
Melatonergic Receptors (Mt1/Mt2) as a Potential Additional Target of Novel Drugs for Depression
Boiko, D. I., Shkodina, A. D., Hasan, M. M., Bardhan, M., Kazmi, S. K., Chopra, H., Bhutra, P., Baig, A. A., & Skrypnikov, A. M. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03646-5 · Cited by 72
Begenisic, T., Baroncelli, L., Sansevero, G., Milanese, M., Bonifacino, T., Bonanno, G., Cioni, G., Maffei, L., & Sale, A. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.11.010 · Cited by 68
Shapiro, L. P., Parsons, R. G., Koleske, A. J., & Gourley, S. L. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.23960 · Cited by 70
Galloway, E. M., Woo, N. H., & Lu, B. (2008) · Progress in brain research · doi:10.1016/s0079-6123(07)00015-5 · Cited by 67
Xu, X., Yang, H., Lin, Y., Li, X., Cape, A., Ressler, K. J., Li, S., & Li, X. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013032107 · Cited by 64
Gender differences in the enhanced vulnerability of BDNF+/− mice to mild stress
Advani, T., Koek, W., & Hensler, J. G. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709000248 · Cited by 60
Immune dysregulation in depression: Evidence from genome-wide association
Tubbs, J. D., Ding, J., Baum, L., & Sham, P. C. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100108 · Cited by 66
Espinera, A. R., Ogle, M. E., Gu, X., & Li, W. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.011 · Cited by 63
Hazra, S., Kumar, S., Saha, G. K., & Mondal, A. C. (2017) · Psychiatry Investigation · doi:10.4306/pi.2017.14.1.74 · Cited by 63
Sales, A. J., & Joca, S. R. L. (2016) · Acta Neuropsychiatrica · doi:10.1017/neu.2015.40 · Cited by 62
Enhanced cognitive function and antidepressant-like effects after krill oil supplementation in rats
Wibrand, K., Berge, K., Messaoudi, M., Duffaud, A. M., Panja, D., Bramham, C. R., & Burri, L. (2013) · Lipids in Health and Disease · doi:10.1186/1476-511x-12-6 · Cited by 62
Coppens, C. M., Siripornmongcolchai, T., Wibrand, K., Alme, M. N., Buwalda, B., de Boer, S. F., Koolhaas, J. M., & Bramham, C. R. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00072 · Cited by 61
Advances in the Preclinical Study of Some Flavonoids as Potential Antidepressant Agents
Germán-Ponciano, L. J., Rosas-Sánchez, G. U., Rivadeneyra-Domínguez, E., & Rodríguez‐Landa, J. F. (2018) · Scientifica · doi:10.1155/2018/2963565 · Cited by 61
Metadata
- Authors
- Rantamäki, T., Hendolin, P., Kankaanpää, A., Mijatovic, J., Piepponen, P., Domenici, E., Chao, M. V., Männistö, P. T., & Castrén, E.
- Affiliations
- University of Helsinki (FI)
- GlaxoSmithKline (Italy) (IT)
- NYU Langone Health (US)
- ORCID
- Venue
- Neuropsychopharmacology
- Published
- 2007-02-21
- Volume
- 32
- Issue
- 10
- Pages
- 2152-2162
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2064468814
- Cited by
- 305
- References
- 75
- Citations by year
- 2026: 8 · 2025: 5 · 2024: 18 · 2023: 17 · 2022: 15 · 2021: 15 · 2020: 18 · 2019: 18 · 2018: 14 · 2017: 20 · 2016: 13 · 2015: 16 · 2014: 15 · 2013: 18 · 2012: 20
- FWCI
- 12.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Iris (University of Trento) (submittedVersion)
- Funders
- GlaxoSmithKline
- Academy of Finland
- Suomen Kulttuurirahasto
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- antidepressants, TrkB receptor, brain-derived neurotrophic factor, phospholipase C-gamma1, CREB, monoamine transporters, citalopram, reboxetine, serotonin depletion, norepinephrine depletion, anterior cingulate cortex, hippocampus, forced swim test, monoamine signaling
- MeSH terms
- Reboxetine, Animals, Antidepressive Agents, Binding Sites, Brain, Brain Chemistry, Depressive Disorder, Gyrus Cinguli, Hippocampus, Male, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Transgenic, Morpholines, Phosphorylation, Citalopram, Signal Transduction, Up-Regulation, Cyclic AMP Response Element-Binding Protein, Selective Serotonin Reuptake Inhibitors, Adrenergic Uptake Inhibitors, Brain-Derived Neurotrophic Factor, Receptor, trkB, Mice, Phospholipase C gamma
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.